Search
Patexia Research
Case number 1:25-cv-00449

Merck Sharp & Dohme LLC v. Aurobindo Pharma Limited et al > Documents

Date Field Doc. No.Description (Pages)
Jul 1, 2025 8 PROPOSED CONSENT JUDGMENT by Merck Sharp & Dohme LLC. (Joyce, Alexandra) (Entered: 07/01/2025) (3)
Jul 1, 2025 9 CONSENT JUDGMENT (CASE CLOSED). Signed by Judge Colm F. Connolly on 7/1/2025. (mws) (Entered: 07/01/2025) (3)
Jul 1, 2025 10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 Consent Judgment)(mws) (Entered: 07/01/2025) (0)
Apr 16, 2025 N/A Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (alb) (Entered: 04/16/2025) (0)
Apr 16, 2025 7 STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) (Entered: 04/16/2025) (2)
Apr 11, 2025 1 COMPLAINT against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4660319) - filed by Merck Sharp & Dohme LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 04/11/2025) (0)
Apr 11, 2025 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 04/11/2025) (3)
Apr 11, 2025 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/25/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/25/2027. (oam) (Entered: 04/11/2025) (2)
Apr 11, 2025 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (oam) (Entered: 04/11/2025) (1)
Apr 11, 2025 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by Merck Sharp & Dohme LLC. (oam) (Entered: 04/11/2025) (1)
Apr 11, 2025 6 Summons Issued as to Aurobindo Pharma Limited on 4/11/2025; Aurobindo Pharma USA, Inc. on 4/11/2025. (Attachments: # 1 Summons Issued)(oam) (Entered: 04/11/2025) (0)
Menu